Search

everythinglearnresearchcommunity

for

Search:↓

Targeted immune modulation can help achieve stable remission in alopecia areata.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Inflammation in hair follicles is a key risk factor for developing common baldness.

COVID-toes show a unique immune response over time, different from vaccine-related chilblains.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

New treatments for alopecia are being explored due to the limitations of current options.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

The patient's hair loss is most likely due to diffuse alopecia areata.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Wound healing is complex and requires more research to enhance treatment methods.

Androgenetic alopecia in women may be improved by targeting oxidative stress, inflammation, and fibrosis.

People with hair loss have low zinc levels; zinc supplements and laser therapy may help.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Woman has discoid lupus, frontal fibrosing, and androgenetic alopecia.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

Psoriasis or contact dermatitis can override alopecia areata, allowing hair growth.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Rubbing seborrheic keratoses causes specific skin changes and may link them to hair follicles.

Some hair loss drugs can cause a unique type of hair loss that resembles both psoriasis and alopecia.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Scalp biopsies are essential for accurately diagnosing alopecia areata.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Reducing micro-inflammation didn't change hair growth patterns in AGA.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.